16 January 2025 A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal Circuit restored Novartis’ patent and overturned a decision in favour of MSN | Request is one in a flurry of filings between the pair over the heart-failure drug.
16 January 2025
16 January 2025
16 January 2025
14 January 2025
14 January 2025
9 January 2025
Latest Features
Americas
Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.
Americas
The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.
Americas
Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade Intelectual and Jeffrey Morton of Haynes and Boone.
Asia
Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Asia
The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP
Asia
Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP.
Biotechnology
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert.
More News
9 January 2025 Skilled in microbiome, medical devices and next generation diagnostics, the new partner is skilled in creating IP strategies for startups, spinouts and SMEs.
9 January 2025 PTAB determines all but one of challenged claims unpatentable | Decision is latest instalment in clash over electrocardiogram technology | Apple bid to stop ‘AliveCor’s rampant infringement’ backfires.
7 January 2025 Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue.
7 January 2025 Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | Court finds Ravgen’s method for preserving DNA in blood samples not obvious.
7 January 2025 Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences group | Shoosmiths adds team in London to expand brand-focused IP services.
7 January 2025 New partner brings technical background in computer science and more than a decade experience in patent litigation | Expertise in tech, engineering, chemical, and life sciences sectors.
2 January 2025 The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company’s proposed generic version of a key ALS drug.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox